Joseph Douglas Lyon Corcept Therapeutics Inc (CORT) insider trading activity

Joseph Douglas Lyon is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 9,009 shares of CORT, which is worth approximately $492,161. The most recent transaction as insider was on Apr 04, 2024, when has been sold 5,443 shares (Common Stock) at a price of $26.0 per share, resulting in proceeds of $141,518. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.01K

8.16% 3M change

43.0% 12M change

Total Value Held $492,161

Joseph Douglas Lyon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 04 2024	SELL Open market or private sale	$141,518 $26.0 p/Share	5,443 Reduced 42.67%	7,314 Common Stock
Apr 04 2024	BUY Exercise of conversion of derivative security	$61,778 $11.35 p/Share	5,443 Added 29.91%	12,757 Common Stock
Apr 01 2024	SELL Open market or private sale	$13,005 $26.01 p/Share	500 Reduced 6.4%	7,314 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$5,675 $11.35 p/Share	500 Added 6.01%	7,814 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$11,404 $24.06 p/Share	474 Reduced 7.0%	6,300 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	$12,198 $12.03 p/Share	1,014 Added 12.18%	7,314 Common Stock
Feb 16 2024	SELL Open market or private sale	$26,000 $26.0 p/Share	1,000 Reduced 12.86%	6,774 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	$11,350 $11.35 p/Share	1,000 Added 11.4%	7,774 Common Stock
Dec 04 2023	SELL Open market or private sale	$63,232 $26.0 p/Share	2,432 Reduced 29.35%	5,854 Common Stock
Dec 04 2023	BUY Exercise of conversion of derivative security	$27,603 $11.35 p/Share	2,432 Added 22.69%	8,286 Common Stock
Dec 01 2023	SELL Open market or private sale	$66,768 $26.0 p/Share	2,568 Reduced 30.49%	5,854 Common Stock
Dec 01 2023	BUY Grant, award, or other acquisition	$11,950 $12.99 p/Share	920 Added 11.96%	6,774 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$29,146 $11.35 p/Share	2,568 Added 23.37%	8,422 Common Stock
Nov 02 2023	SELL Open market or private sale	$111,793 $28.11 p/Share	3,977 Reduced 40.45%	5,854 Common Stock
Nov 02 2023	BUY Exercise of conversion of derivative security	$45,138 $11.35 p/Share	3,977 Added 28.8%	9,831 Common Stock
Nov 01 2023	SELL Open market or private sale	$28,725 $28.08 p/Share	1,023 Reduced 14.88%	5,854 Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	$11,611 $11.35 p/Share	1,023 Added 12.95%	6,877 Common Stock
Oct 06 2023	SELL Open market or private sale	$70,333 $27.24 p/Share	2,582 Reduced 30.61%	5,854 Common Stock
Oct 06 2023	BUY Exercise of conversion of derivative security	$29,305 $11.35 p/Share	2,582 Added 23.43%	8,436 Common Stock
Oct 02 2023	SELL Open market or private sale	$65,890 $27.25 p/Share	2,418 Reduced 29.23%	5,854 Common Stock
Oct 02 2023	BUY Exercise of conversion of derivative security	$27,444 $11.35 p/Share	2,418 Added 22.62%	8,272 Common Stock
Sep 01 2023	SELL Open market or private sale	$163,649 $32.73 p/Share	5,000 Reduced 49.35%	5,132 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	$11,949 $16.55 p/Share	722 Added 10.98%	5,854 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$56,750 $11.35 p/Share	5,000 Added 33.04%	10,132 Common Stock
Aug 21 2023	SELL Open market or private sale	$143,099 $31.19 p/Share	4,588 Reduced 47.2%	5,132 Common Stock

JDL

Joseph Douglas Lyon

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account